Table 4.
Distribution of the results of 91 serum samples using the 4 Widal brands for anti-O antibodies in relation to their corresponding IgM anti-LPS ELISA results using a cut-off 1/320
Widal brand | anti-O titer ≥ 1/320 |
ELISA (91) | Total | |||
---|---|---|---|---|---|---|
Positive (67) | Negative (24) | |||||
Number | % | Number | % | |||
Remel (91) | Negative | 27 | 40.29 | 24 | 100.00 | 51 |
Positive | 40 | 59.7 | 0 | 0.00 | 40 | |
Biosystems (91) | Negative | 36 | 53.73 | 24 | 100.00 | 60 |
Positive | 31 | 46.26 | 0 | 0.00 | 31 | |
Biotech (91) | Negative | 43 | 64.17 | 24 | 100.00 | 67 |
Positive | 24 | 35.82 | 0 | 0.00 | 24 | |
Dialab (91) | Negative | 65 | 97.01 | 24 | 100.00 | 89 |
Positive | 2 | 2.98 | 0 | 0.00 | 2 |